IP Library Granted Patent US 8,399,252
Granted Patent B2
US 8,399,252 · App. 12/570,032 · Granted Mar 19, 2013

Methods and kits for cell release

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,399,252
App. No.
12/570,032
Granted
Mar 19, 2013
Kind
B2
Abstract

Methods and kits of releasing cells are provided. The method comprises the steps of providing cultured cells on a cell culture support comprising a multi layer polyelectrolyte coating immobilized on a substrate, and releasing the cultured cells from the cell culture support by a releasing solution comprising DMSO. The kit comprises a cell culture support and a releasing solution. The releasing solution comprises DMSO.

Claims (17)

1. A method of releasing cells, comprising:

a) providing cultured cells on a cell culture support, wherein the cell culture support comprises a multi-layer polyelectrolyte coating immobilized on a substrate, wherein the multi layer polyelectrolyte coating comprises at least one layer of poly-(di(ethyleneglycol)methylether methacrylate)-co-polyacrylic acid and

b) releasing the cultured cells from the cell culture support by adding a releasing solution comprising DMSO,

wherein the cells are selected from the group consisting of embryonic stem cells, adult stem cells, induced pluripotent stem cells, dendritic cells, hematopoietic cells, mesenchymal stromal cells, neural cells, reprogrammed cells and de-differentiated cells.

2. The method of claim 1 , wherein the cultured fragile cells comprise mesenchymal stromal cells.

3. The method of claim 1 , wherein the cultured fragile cells comprise human mesenchymal stromal cells.

4. The method of claim 1 , wherein concentration of DMSO in the releasing solution ranges from about 0.01% to 1.0%.

5. The method of claim 1 , wherein concentration of DMSO in the releasing solution ranges from about 0.02% to 0.5%.

6. The method of claim 1 , wherein concentration of DMSO in the releasing solution ranges from about 0.1% to 0.5%.

7. The method of claim 1 , wherein the cultured cells are released from the cell culture support by incubating the cell culture support at room temperature.

8. The method of claim 7 , wherein the incubation is performed for about 10 to 30 minutes.

9. The method of claim 1 , wherein the multi layer polyelectrolyte coating comprises at least one homopolymer layer.

10. The method of claim 1 , wherein the multi layer polymer coating comprises an alternating arrangement of a poly-(di(ethyleneglycol)methylether methacrylate)-co-polyacrylic acid layer and a homopolymer layer.

11. The method of releasing cells of claim 1 , wherein the multi layer polyelectrolyte coating comprises at least one layer of poly-L-lysine.

12. A method of releasing human mesenchymal stem cells, comprising:

a) providing cultured human mesenchymal stem cells on a cell culture support, wherein the cell culture support comprises a multi-layer polyelectrolyte coating immobilized on a substrate, wherein the multi-layer polyelectrolyte coating comprises at least one poly-(di(ethyleneglycol)methylether methacrylate)-co-polyacrylic acid layer; and

b) releasing the cells from the cell culture support at room temperature, by incubating with a releasing solution comprising about 0.1% DMSO.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2020
From: GENERAL ELECTRIC COMPANY
To: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Reel/Frame 053966/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2009
From: RUBINSZTAJN, SLAWOMIR; SUSARLA, PRAMEELA; SMITH, REGINALD DONOVAN; LOGHIN, EVELINA ROXANA
To: GENERAL ELECTRIC COMPANY
Reel/Frame 023426/0318 →